Cosmetic Laser Dermatology Publishes Research on Diverse Population Treatment, Exosomes, & Acne Scars

San Diego, CA, December 21, 2023 – Cosmetic Laser Dermatology is pleased to share that three of its board-certified dermatologists — Mitchel Goldman, MD, Sabrina Fabi, MD, and Jameson Loyal, MD — participated in several groundbreaking research studies published earlier this year. The seven topics covered include the treatment of diverse patient populations, the use of fibroblast-derived growth factors and exosomes, and acne scar treatment with radiofrequency microneedling and nonablative fractional laser devices.

“As a team, we’ve always believed in the power of research to enhance patient care and broaden our understanding of dermatological treatments. It’s a privilege to be at the forefront of such pioneering work, and I am particularly proud of our team for their dedication and expertise in pushing the boundaries of cosmetic dermatology,” said Dr. Goldman, Founder and Medical Director of Cosmetic Laser Dermatology.

Dr. Goldman participated in a research review titled “Fibroblast‐derived growth factors and exosomes as cosmeceuticals,” published in Dermatological Reviews. The study explored how these essential components in skincare contribute to improving aged and photodamaged skin. The results indicated that these components have the potential to enhance skin structure, function, and quality.

Dr. Fabi contributed to five articles discussing aesthetic considerations when treating patients of African, Latin American, Middle Eastern, Asian, and North American multi-ethnic descent. The articles, which discussed how dermatologists can more effectively treat individuals within these populations, were published in the Journal of Cosmetic Dermatology.

Dr. Loyal and Dr. Goldman both participated in a study titled “Alternating Treatment With Nonablative Fractional Laser and Radiofrequency Microneedling for the Treatment of Acne Scars: A Prospective, Randomized, Split-Face Study,” published in Dermatologic Surgery.

The study investigated the effectiveness of alternating nonablative fractional lasers (NAFL) and radiofrequency microneedling compared to NAFL alone in treating atrophic acne scars. The results showed that although both treatments are safe in addressing acne scars, alternating them does not seem superior to using NAFL alone.

About Dr. Goldman

Dr. Goldman is considered a leading medical authority worldwide, authoring 14 medical textbooks and over 350 peer-reviewed medical publications. He is the founder and medical director of Cosmetic Laser Dermatology and medical director of West Dermatology and Platinum Dermatology Partners. He is recognized for pioneering research on multiple laser techniques, skin rejuvenation, liposculpture, and vein therapy.

About Dr. Fabi

Dr. Fabi is an internationally recognized leader in cosmetic dermatology and the associate research director at Cosmetic Laser Dermatology. She has authored over 160 medical articles and co-authored 25 book chapters. She has also lectured and taught nationally and internationally in over 40 countries in English and Spanish to more than 80,000 physicians.

About Dr. Loyal

Dr. Loyal has been an investigator for more than 50 clinical trials, working with a wide range of major pharmaceutical, device, and cosmetic companies. Many of these studies have been conducted to obtain FDA approval or clearance. Dr. Loyal also serves as an expert consultant to pharmaceutical and medical device companies, and he publishes extensively in peer-reviewed medical journals and textbooks.

Meet Emily Mitchell, our dedicated Senior Business Analyst here at Business Press Daily. Emily’s role is pivotal in our mission to provide you with accurate, data-driven insights into the business world. With her extensive background in business analysis, she dissects complex data, identifies key trends, and translates them into actionable recommendations.